Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 923-927-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- Titanium 2-hydroxy-1,2,3-propanetricarboxylate (2:5)
- EC Number:
- 923-927-0
- Molecular formula:
- C30H32O35.Ti2
- IUPAC Name:
- Titanium 2-hydroxy-1,2,3-propanetricarboxylate (2:5)
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Dihydrogen oxide
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- (1) Product name : CTL Ti638 UP
(2) CAS No. : Not available
(3) Lot No. : 110200/51
(4) Facility code No. : 2015/00032
(5) Received date : 26 May, 2015
(6) Appearance : Orange, particulate free liquid
(7) Purity : 54.7 wt.% (Ti content 4.97 wt.%)
(8) Storage condition : Room temperature
(9) Supplier : Catalytic Technologies Limited
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- NTacSAM:SD
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Date of acquisition
- 1st acquisition : 25 June 2015
- 2nd acquisition : 10 July 2015
Number of animals received : Each 7 female rats per acquisition
Age of animals received : About 7 weeks
Body weights on arrival
- 1st acquisition : 174.89 - 189.04 g
- 2nd acquisition : 169.87 - 178.27
Quarantine and acclimation: Animals were acclimated for 5 (first step), 12 (second step), 6 (third step) and 13 (forth step) days. Only animals with the best appearance were selected for the test after observation during the acclimation period. Animals were accepted based on the certification provided by the supplier
Age at the initiation of the administration : About 8 - 9 weeks
Body weights at the administration
- G1 (1st step 300 mg/kg) : 183.50 - 185.36 g
- G2 (2nd step 300 mg/kg) : 180.02 - 194.07 g
- G3 (3rd step 2,000 mg/kg) : 181.95 - 184.09 g
- G4 (4th step 2,000 mg/kg) : 194.33 - 199.87 g
Number of animals administered: Three female rats were used in each step. The test substance was administered to total twelve female rats.
Grouping: Animals were weighed one day before the test substance administration and grouped to ensure a distribution of graded body weight. Animals whose body weights fall in an interval within ±20% of the mean weight are only used.
Environmental and Housing Condition
(1) Animal care room : Room 1 in the SPF animal facility area.
(2) Temperature and humidity : 23.6±0.9 °C and 58.3±3.6%RH
(3) Ventilation frequency : 10-15 air changes/hours
(4) Lighting cycle : 12 hours duration (lighting on at 8 a.m. and off at 8 p.m.)
(5) Lighting intensity : 281 Lux
(6) Noise : 56.2 dB
(7) Concentration of ammonia : less than 5 ppm
(8) Housing condition
All animals were housed in wire mesh cages (250W × 350L × 180H mm) during quarantine, acclimation, administration and observation period. During the experiment, not more than 3 animals were housed in a cage and cages were replaced at grouping.
Feeds and water
Radiation sterilized, solid laboratory animal feed (Teklad Certified Irradiated Global 18 % Protein Rodent Diet, Harlan Co. Ltd., USA) was provided ad libitum. DooYeol Biotech Co., Ltd. (91, Baumoe-ro, Seocho-gu, Seoul, Korea) supplied the feed. Tap water purified by reverse osmosis filtering system was provided ad libitum using water polycarbonate bottles.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 300 mg/kg and 2000 mg/kg
- No. of animals per sex per dose:
- 3 females per dose
- Details on study design:
- Clinical signs and mortalities
General clinical signs or mortalities of all treated animals were carefully observed continuously during the first half-hour and the one hour from the
administration time. After that, all animals were observed regularly at one hour intervals until four hours on the administration day. From the next
day, animals were observed once every day up to day 14 after the administration. The administration day was regarded as day 0.
Body weight measurement
Individual animals were weighed at the date of acquisition, at grouping, dosing day prior to administration (on the administration day), on day 1, 7
and 14 (before necropsy) after administration.
Necropsy and gross findings examination
On 14 days after the administration, all survival animals were anesthetized with CO2 gas and terminated by exsanguination from the abdominal aorta
and caudal vena cava. Complete post-mortem examinations were performed on all vital organs. - Statistics:
- Body weight changes of all animals in each step were analysed through tables and figures that were applied to the mean value and the standard
deviations. Additional statistical assessment was not performed in data analysis. The LD50 value was classified according to the study procedure diagram of OECD Guideline for the Testing of Chemicals No. 423 ‘Acute Toxic Class Method’ (Adopted 17th Dec., 2001).
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities were observed during the observation period at either dose level.
- Clinical signs:
- other: At 300 mg/kg no abnormal clinical signs were observed during the observation period. At 2000 mg/kg 1/6 animal had inanimation and diarrhea on administration day. After that, emaciation, crawling position and paralytic gait were observed. In additon, black
- Gross pathology:
- At 300 mg/kg no abnormal gross findings were observed.
At 2000 mg/kg loss of digits and distal part of tail were observed in 1/6 animal. Except that, no abnormal gross findings were observed.
Any other information on results incl. tables
Table 1. Mortalities and clinical signs of rats
SUMMARY OF MORTALITIES AND CLINICAL SIGNS |
|||||
STUDY : GT15-00104 |
SEX : FEMALE |
||||
GROUP(㎎/㎏ |
|||||
G1(300) |
G2(300) |
G3(2,000) |
G4(2,000) |
||
MORTALITIES |
N |
0 / 3 |
0 / 3 |
0 / 3 |
0 / 3 |
% |
0 |
0 |
0 |
0 |
|
CLINICAL SIGNS |
No abnormalities detected |
3 / 3 |
3 / 3 |
3 / 3 |
3 / 3 |
Diarrhea |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Soiled perineal region |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Inanimation |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Emaciation |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Black skin, distal part of foot, right |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Black skin, distal part of tail |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Crawling position |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Paralytic gait |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Hypoesthesia |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Loss of tail, distal part |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
|
Loss of digits, right |
0 / 3 |
0 / 3 |
1 / 3 |
0 / 3 |
Number of dead animals / Number of animals examined
Table 2. Body weight changes of rats
SUMMARY OF BODY WEIGHT CHANGES(g) |
||||
STUDY : GT15-00104 |
SEX : FEMALE |
|||
Day |
GROUP(㎎/㎏) |
|||
G1(300) |
G2(300) |
G1(2,000) |
G2(2,000) |
|
0 |
184.45 ± 0.93 (3) |
187.66 ± 7.11 (3) |
182.84 ± 1.12 (3) |
197.42 ± 2.82 (3) |
1 |
208.72 ± 0.39 (3) |
201.54 ± 8.19 (3) |
191.78 ± 17.08 (3) |
215.79 ± 15.55 (3) |
7) |
219.60 ± 4.01 (3 |
219.38 ± 8.96 (3) |
202.75 ± 18.86 (3) |
228.83 ± 10.08 (3) |
14 |
241.00 ± 6.42 (3) |
228.12 ± 12.18 (3) |
215.33 ± 17.94 (3) |
248.84 ± 10.86 (3) |
Gaina |
56.55 ± 5.59 (3) |
40.46 ± 5.26 (3) |
32.49 ± 17.56 (3) |
51.42 ± 9.83 (3) |
Mean±S.D (Number of animals)
a : Body weight gains between day 0 and 14
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The acute oral lethal dose 50 (LD50) of the test substance CTL Ti638 UP is considered greater than 2,000 ㎎/㎏ b.w. and it belongs to the GHS
category 5 under these study conditions. - Executive summary:
This study has been performed to evaluate the lethal dose 50 (LD50) and toxicity of the test substance CTL Ti638 UP when it was administered in single oral dose to Sprague-Dawley (SD) female rats. The test substance was administrated by gavage at the dose level of 300 ㎎/㎏ in two steps (the first and second step) and at the dose level of 2,000 ㎎/㎏ in two step (the third and forth step). During the study period, dead animals, clinical signs, body weight changes and gross findings at necropsy were examined.
1) In the first and second steps (300 ㎎/㎏), no mortalities and abnormal clinical signs were observed during the observation period. There were normal body weight gains in all animals. At the end of the study, necropsy was conducted to all animals and no abnormal gross findings were observed.
2) In the third and forth steps (2,000 ㎎/㎏), 1/6 animal had inanimation and diarrhea on administration day. After that, emaciation, crawling position and paralytic gait were observed. In additon, black discoloration and hypoesthesia
of distal parts of right foot and tail were revealed and those parts eventually were lost. Hypoesthesia and paralytic gait were maintained until necropsy. Except that, there were no abnormal clinical signs in other animals.
In body weights, temporary decrease was detected in 1/6 animal. Except that, there were normal body weight gains.
At the results of necropsy, loss of digits and distal part of tail were observed in 1/6 animal. Except that, no abnormal gross findings were observed.
Therefore, the acute oral lethal dose 50 (LD50) of the test substance CTL Ti638 UP is considered greater than 2,000 ㎎/㎏ b.w. and it belongs to the GHS category 5 under these study conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.